BHAKTI KANANI: Open Payments
NPI 1215126693 · OLD BRIDGE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$791 in 38 payments from 17 companies in 2025. Trend: 2023 $171 · 2024 $514 · 2025 $791
Food & beverage: $694Education: $97
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $142 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $121 |
| SANOFI-AVENTIS U.S. LLC | 1 | $97 |
| ABBVIE INC. | 5 | $91 |
| GENZYME CORPORATION | 4 | $77 |
| Janssen Biotech, Inc. | 3 | $64 |
| Galderma Laboratories, L.P. | 2 | $31 |
| LEO Pharma Inc. | 1 | $23 |
| Incyte Corporation | 1 | $18 |
| UCB, Inc. | 1 | $18 |
Products named: DUPIXENT, TREMFYA, Rhapsido, SKYRIZI, NEMLUVIO, ANZUPGO, OPZELURA, Bimzelx.
Industry payments across NJ — which companies pay providers there.
